Why is Eiko Lifescience falling/rising?

As of 14-Jul, Eiko Lifesciences Ltd is experiencing a price increase, currently at 56.64, reflecting a change of 0.64 or 1.14% upward. The stock has shown a trend reversal, gaining after three consecutive days of decline. Despite a recent underperformance with a 6.18% drop over the past week, it has outperformed its sector today by 1.06%. The stock's moving averages indicate it is currently higher than the 20-day, 50-day, 100-day, and 200-day averages, although it is lower than the 5-day moving average. Additionally, promoter confidence has risen, with a 4.96% increase in their stake, suggesting optimism about the company's future, despite the weak long-term fundamentals indicated by a low return on equity of 2.82% and a significant drop in net sales.
In the broader market context, Eiko Lifesciences' short-term performance contrasts with the benchmark, as it has declined by 6.18% over the past week while the Sensex has only fallen by 1.42%. Over the past month, however, the stock has gained 11.74%, significantly outperforming the Sensex's 1.40% increase. Despite these positive short-term movements, the stock has underperformed over longer periods, with a year-to-date return of -9.72% compared to the Sensex's 5.27%. This mixed performance highlights the challenges the company faces in maintaining investor confidence amidst fluctuating market conditions.